Evidence map›Paper›PMID 33773529›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2021

The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres.

Laureline Gatellier, Abhishek Shankar, Luh K Mela Dewi, Quazi Mushtaq Hussain, Tashi Dendup Wangdi, Dato Babu Sukumaran, Nina Kemala Sari, Sahar Tavakkoli Shiraji, Mohammad Biglari, Mamak Tahmasebi and 23 more

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Experiences of patients and providers while using telemedicine in cancer care during COVID-19 pandemic: a systematic review and meta-synthesis of qualitative literature.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  2. Article
  3. Impact of the COVID-19 and Socioeconomic Status on Access to Care for Otorhinolaryngology Patients.International journal of environmental research and public health · 2022
    Article
  4. Article
  5. Article
  6. Decreased Global Interest in Oral Cancer During the COVID-19 Pandemic.Asian Pacific journal of cancer prevention : APJCP · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Laureline GatellierNational Cancer Center, Tokyo, Japan.ORCID 0000-0002-0331-3235
Abhishek ShankarLady Hardinge Medical College & Associated Hospitals, Delhi, India.
Luh K Mela DewiDharmais Hospital - National Cancer Center, Jakarta, Indonesia.
Quazi Mushtaq HussainNational Institute of Cancer Research and Hospital, Dhaka, Bangladesh.
Tashi Dendup WangdiJDWNR Hospital Thimphu University of Medical Sciences, Bhutan.
Dato Babu SukumaranThe Brunei Cancer Centre, Brunei Darussalam.
Nina Kemala SariDharmais Hospital - National Cancer Center, Jakarta, Indonesia.
Sahar Tavakkoli ShirajiHematology, Oncology and Bone Marrow transplantation Research Center, Shariati Hospital, Tehran University of Medical Science,Tehran, Iran.
Mohammad BiglariHematology, Oncology and Bone Marrow transplantation Research Center, Shariati Hospital, Tehran University of Medical Science,Tehran, Iran.
Mamak TahmasebiCancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Satoshi IwataNational Cancer Center, Tokyo, Japan.
Tatsuya SuzukiNational Cancer Center, Tokyo, Japan.
Seung-Kwon MyungNational Cancer Center of Korea, Goyang-si Gyeonggi-do, Republic of Korea.
June Young ChunNational Cancer Center of Korea, Goyang-si Gyeonggi-do, Republic of Korea.
Jong Soo HanNational Cancer Center of Korea, Goyang-si Gyeonggi-do, Republic of Korea.
Fen Nee LauNational Cancer Institute, Putrajaya, Malaysia.
Suhana YusakNational Cancer Institute, Putrajaya, Malaysia.
Luvsandorj BayarsaikhanNational Cancer Center of Mongolia, Ulaanbaatar, Mongolia.
Khin Thin MuMyanmar Yangon General Hospital, Yangon, Myanmar.
Kishore K PradhanangaKathmandu Cancer Center, Bhaktapur, Nepal.
Aasim YusufShaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan.ORCID 0000-0003-1943-2746
Ching-Hung LinNational Taiwan University Cancer Center Hospital, Taipei City, Taiwan.
Ruru Chun-Ju ChiangTaiwan Cancer Registry, and Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Suleeporn SangrajranNational Cancer Institute, Bangkok, Thailand.
Quang Tien NguyenNational Cancer Institute, National Cancer Hospital, Hanoi, Vietnam.
Giang Nguyen HuongNational Cancer Institute, National Cancer Hospital, Hanoi, Vietnam.
Aung Naing SoeCity Cancer Challenge Foundation, Geneva, Switzerland.
D N SharmaDr BR Ambedkar Institute Rotary Cancer Hospital & National Cancer Institute, All India Institute of Medical Sciences, Delhi, India.
Manju SengarTata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
C S PrameshTata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Tomohiro MatsudaNational Cancer Center, Tokyo, Japan.
Alireza Mosavi JarrahiMedical School, Shahid Behshti University of Medical Sciences, Tehran, Iran.
William HwangNational Cancer Centre, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe COVID-19 pandemic has dramatically affected healthcare services around Asia. The Asian National Cancer Centres Alliance and the Asia-Pacific Organisation for Cancer Prevention collaborated to assess the mid- and long- term impact of COVID-19 to cancer care in Asia.

methodsThe two entities organised a combined symposium and post-meeting interactions among representatives of major cancer centres from seventeen Asian countries to outlining major challenges and countermeasures.

resultsParticipating stakeholders distilled five big questions. 1) "Will there be an explosion of late-stage cancers after the pandemic?" To address and recover from perceived delayed prevention, screening, treatment and care challenges, collaboration of key stakeholders in the region and alignment in cancer care management, policy intervention and cancer registry initiatives would be of essential value. 2) "Operations and Finance" The pandemic has resulted in significant material and financial casualties. Flagged acute challenges (shortages of supplies, imposition of lockdown) as well as longer-standing reduction of financial revenue, manpower, international collaboration, and training should also be addressed. 3) "Will telemedicine and technological innovations revolutionize cancer care?" Deploying and implementing telemedicine such as teleconsultation and virtual tumour boards were considered invaluable. These innovations could become a new regular practice, leading to expansion of tele-collaboration through collaboration of institutions in the region. 4) "Will virtual conferences continue after the pandemic?" Virtual conferences during the pandemic have opened new doors for knowledge sharing, especially for representatives of low- and middle-income countries in the region, while saving time and costs of travel. 5) "How do we prepare for the next pandemic or international emergency?" Roadmaps for action to improve access to appropriate patient care and research were identified and scrutinised.

conclusionThrough addressing these five big questions, focused collaboration among members and with international organisations such as City Cancer Challenge will allow enhanced preparedness for future international emergencies.<br />.

Indexed as

COVID-19TelemedicineAsiaCancer Care FacilitiesCommunicable Disease ControlCongresses as TopicDelayed DiagnosisDelivery of Health CareHumansNeoplasmsSARS-CoV-2VideoconferencingAsiaCoronavirusDiagnosisLMICPrevention

Identifiers

PMID33773529
PMCPMC8286686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.